Clinical Trial Update: Neo-adjuvant Treatment for Squamous Cell Carcinoma Using Direct Tumor Injection With RP1. [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating direct tumor injections of RP1 as neoadjuvant therapy for squamous cell carcinoma; the study is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma

Drugs mentioned

• RP1

Snippet

Sponsor: Sherrif Ibrahim | Conditions: Squamous Cell Carcinoma, RP1 | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING